Results 31 to 40 of about 6,357 (207)
Український Журнал Нефрології та Діалізу, 2014 Summary. The aim of the present research was to study the influence of еpoetin alfa to the level of pro- and anti-inflammatory cytokines in patients with anemia treated by hemodialysis (HD).
I. Dudar +4 more
doaj +1 more source
Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study [PDF]
, 2016 Background Since 2007 biosimilars of erythropoiesis-stimulating agents (ESAs) are available on the Italian market. Very limited post-marketing data exist on the comparative effectiveness of biosimilar and originator ESAs.
Alibrandi, A. (Angela) +12 more
core +6 more sources
Sensitivity and specificity of detection methods for erythropoietin doping in cyclists [PDF]
, 2019 Recombinant human erythropoietin (rHuEPO) is used as doping a substance. Anti-doping efforts include urine and blood testing and monitoring the athlete biological passport (ABP).
Burggraaf, Jacobus +10 more
core +1 more source
Should We Use Preoperative Epoetin-α in the Mildly Anemic Patient Undergoing Simultaneous Total Knee Arthroplasty? [PDF]
, 2013 Simultaneous knee arthroplasty is associated with significant blood loss. To prevent transfusion, three preoperative doses of epoetin-α were offered to mildly anemic simultaneous knee arthroplasty patients.
Blair, Jamie L +4 more
core +2 more sources
Effect of Epoetin Alfa and Sodium Valproate in Patients with Myelodysplastic Syndrome
Novelty in Biomedicine, 2020 Background: Myelodysplastic syndrome (MDS) is an important precancerous disease leading to blood malignancies. Prompt diagnosis and treatment would result in better outcome in patients. Purpose of the study was to determine the effect of Epoetin Alfa and
Seyed Ashkan Hosseini +2 more
doaj +1 more source
Indonesian Journal of Cancer, 2013 Pada kanker payudara operabel dengan metastasis regional, pemberian kemoterapi ajuvan berbasis antrasiklin dapat menyebabkan terjadinya anemia ringan sampai berat pada sekitar 4% - 63% kasus. Telah dilakukan berbagai penelitian tentang peran epoetin alfa
Dimyati Achmad +3 more
doaj +1 more source
Strategies for the Management of Postoperative Anemia in Elective Orthopedic Surgery [PDF]
, 2016 Objective: To assess the use of oral iron, intravenous (IV) iron, and erythropoiesis-stimulating agents (ESAs) for the prevention and management of perioperative anemia in elective orthopedic surgery patients, and to provide a clinical algorithm for use.
Howard, Meredith L. +2 more
core +2 more sources
Український Журнал Нефрології та Діалізу, 2015 The article describes the ways to cost optimization of anemia treatment CKD - HD patients. Aims. dinical and economic analysis treatment of Anemia CKD VHD PTS with using long action Erythropoiesis Stimulating Agents (ESA). Methods.
M. Kolesnyk, N. Bezdetko, V. Novakivskyy
doaj +1 more source
High Dose ESAs Are Associated with High iPTH Levels in Hemodialysis Patients with End-Stage Kidney Disease: A Retrospective Analysis [PDF]
, 2015 Objective: Anemia and secondary hyperparathyroidism are the two most common complications associated with chronic kidney disease (CKD). Erythropoiesis-stimulating agents (ESAs) are widely used in the management of anemia in hemodialysis patients.
Chun-Hua Lin +4 more
core +2 more sources
Медицинский вестник Юга России, 2013 Purpose: To reveal clinical effects of epoetin alfa in the sharp period the serious сoncomitant brain injury.Materials and Methods: Controllable blind randomized research at 77 patients at the age of 38,6±15,2 years old was held. Epoetin alfa was entered
E. A. Lebedeva +2 more
doaj +1 more source